Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-11

Clinical Trial Update: Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pain and quality of life after mediastinal tumor resection using subxiphoid and intercostal VATS, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lei Jiang | Conditions: Mediastinal Neoplasms, Thoracic Neoplasm | Phase 3 | Status: UNKNOWN